tedevan
Posted - 1 week ago
$MYOV $IOVA
Polip
Posted - 1 week ago
$IOVA sad to see many demotivated. I get it it’s disappointing seeing the portfolio losing. To many hating the volatility I strongly encourage to manage risk or buy the index. I am not saying I am just chilling here. I saw a lot of profit evaporating in a few days scratching my head why. I was also in $MYOV and trust me it took a lot of manipulation and patience before the value was unlocked. the company had written for sale all over the place and price crashed many times I was scratching my head. now Iovance has even more potential, amazing pipeline the best investors in the space and exponential growing revenue. it has written for sale all over the place and it will be sold. is it going to crash? is it going to be shorted like crazy? nobody knows. if you are frustrated like me take a step back go to the fundamentals and remind yourself why you invested in the first place. Probably my post is self therapeutic 😂 but I hope it helps. GL
MRTunity
Posted - 2 months ago
$AUPH speaking to other more educated and informed “biotech investors”.. and examining my charts … I’m convinced a formal BUYOUT is NOT happening this week… still couple weeks away at least.
That said LONGs should INSTEAD be anxiously awaiting 🇯🇵 FDA Approval as “the” catalyst with $XBI and $RUT breaking up and out (now that Quandruple witching OE bullshit is behind propel the stock much higher levels!
We need the market to breakout along with positive press release which will allow the big boys here aka MM’s to push the stock price up to $9-$11 zone in a parabolic fashion at which point consolidate to bring 30D MA from $6.88 up to $7.50+
Such a scenerio opens up possibility of us FINALLY getting that $18-$22 Buyout offer from the likes of a $GILD or at the very least $15 ish low ball offer from those cheap ass Japanese who already fucked me once with $MYOV ! 😤 🤬 Really just need to see the stock price next week break up and over that $7.40 hurdle and runs towards $8+
Kingjake26
Posted - 2 months ago
@PLATINUM_TRADES @IC1101 it’s not a dream
And for your information I made enough to retire on with $CCXI and $MYOV buyouts. A Japan company both them out. It’s a blessing to do research and not trade all
Day trying to make a few bucks while paying a crap ton to do taxes and paying federal and state taxes. I like my long term gains at only 15% tax.
Quad_
Posted - 2 months ago
@gemstar4 I had a 110,000 shares of $MYOV. I was disappointed in the b/o price. But because I had so many shares, I net like $800k out of it. I think that we could get 10-12 easily.... which will almost be Myovant like. But it's no $IMMU, that's for sure.
theDIOyears
Posted - 2 months ago
@IronMynd @BuyHighSellLow14 I agree, listening to the last 2 CC definitely gave me some confidence in their progress with payers and with the financials. It's just a waiting game. I'm going down with the ship. Not letting this one get away like $PRVB or $MYOV
IFeelLucky812
Posted - 08/27/24
$PHAT the script acceleration reminds me of $MYOV , they got taken out for about 3B. That number here gets us north of $40/share.
Dizzo
Posted - 08/25/24
$ARDX 2 out of the 4 I’ve owned on this list have been BO ($PRVB & $MYOV). Wonder if the other two will have the same fate ($ARDX & $AUPH)
NVDAMillionaire
Posted - 2 months ago
$MYOV Myovant Sciences Ltd. (NYSE:MYOV): A Promising Biopharmaceutical Company Navigating Challenges and Opportunities http://beyondspx.com/2024/08/05/myovant-sciences-ltd-nysemyov-a-promising-biopharmaceutical-company-navigating-challenges-and-opportunities/
Polip
Posted - 07/31/24
$DAWN I just saw that they have Lauren Merendino as Chief Commercial Officer! Wow she was very good in $MYOV before it got acquired by Sumitomo. Great leadership!
Rednovember24
Posted - 04/25/24
@cea @bikechain agree. As much as I don’t want it to, I’m fully expecting this to continue in to May. It’s all good, just be patient. I nearly went out of my mind with $MYOV during approval and the buyout. Looking back I wish I’d bought more during the MM attacks, didn’t realize it was accumulation as I suspect is going on here.
Rednovember24
Posted - 7 months ago
@MRTunity @Profitfire I’m also thinking a drop will happen to shake out more weaklings before the news. Sometime I’ll tell y’all about $MYOV. I see a similar replay of history here.
Bigprofits23
Posted - 7 months ago
$MYOV Awww to bad for Sumi after screwing the MYOV stock holders. Corruption has Karma!
https://www.fiercepharma.com/pharma/sumitomo-pharma-lays-another-400-us-staffers-face-sliding-revenues
sempiternal1
Posted - 7 months ago
$ARDX A double indication drug with large TAMs is pretty unusual. It’s even more unusual for it to still be owned by a small pharma. Maximum value for buyouts are generally at <12 months from last approval. I think this company has a better shot than most to get one in the next 6 months. Similar to $MYOV $ALBO. Also, X excitement will drive sp into earnings I imagine.
Overall, I would love to see the bundling issue completely removed (75% chance per RJ report) but dialysis is a margin thin business. My guess is the new hire was brought in to negotiate around this issue and pitch on value as if bundling won’t happen. It’s better to let this ticker go at $16-$20 then let the full picture come into view. You start to run into patent life questions, length of full revenue, DCF gets smaller, etc. Sell big pharma on the dream now and let them fight out the details
GL to all.
Bigprofits23
Posted - 7 months ago
@newandimproveddonkeykong Sooo TRUE! I was in MYOV for 4 years! Yikes. Road from 8 to 31 back to 7’s, then BO at $27.
I knew what I owned even though lowball BO because they had a majority stock holder. Was also in PRVB with the money from MYOV.
In at 7 out at BO of $25. $ARDX seems like a much easier hold and buy than $MYOV or $PRVB. GL!
NobVega
Posted - 8 months ago
$ARQT I said $IMGN and $MYOV would be bought out. I'm saying the same here. I'm only holding 8k shares, but expect a $20 buyout from here.
Lets_Go_Brndn
Posted - 8 months ago
$BTTX Frank talks Tuesday. Listen to what a successful CEO has to say. And don’t forget his involvement in $MYOV. Frank doesn’t know anything but success. “Media” pop-up writes come and go like diarrhea in a diaper. Very similar
west281356
Posted - 9 months ago
@airplaneb747 @R408 reminds me of the $MYOV Take under at $27….
Quad_
Posted - 9 months ago
@stelzer $IMMU and $MYOV were, too.
Bigprofits23
Posted - 01/24/24
@Bamabeast256 If there was evidence it would be illegal, right?
I have been involved in 2 BO’s over the last 15 months. $MYOV & $PRVB ARDX seems to have the best management team out of the 3. That would be the only reason I would say NA to a BO unless it was relatively high. But as I SPECULATE the previous BO’s were $27 & $25 respectively. GL!
RTuckr
Posted - 10 months ago
@Governor_Richie @Elvira007 @Governor_Richie @Elvira007 there would be an announcement saying… MREO has agreed to be bought by XYZ @$9.00. The buyout takes time(2-6months) but in the short term, before the deal finalizes, it would trade at $8.xx - gets closer to 9 the more imminent the date is. Any shares you still own by the acquisition date will turn to cash.
See $MYOV.
fin_researcher
Posted - 11 months ago
$MYOV Myovant Sciences was acquired by Sumitovant of Sumitomo Pharma for $27.00 per share in cash via a merger transaction. Based on J.P. Morgan's valuations for $MYOV, Sumitovant was willing to pay $29.50 per share in a competitive bidding scenario. Investors suspect that they were misled in voting for a merger at a price that was less than Myovant’s full and fair value. https://11thestate.com/cases/myovant-mna-lawsuit
nosoul777
Posted - 11/30/23
$IMGN gosh, I love it when I'm right! Number 5 for me in the past year-ish. $MYOV, $PRVB, $SPPI, $ALBO and now $IMGN. I wish I had more money in here right now, but I'll take a win wherever I get it these days. 🙂
fin_researcher
Posted - 11/27/23
$MYOV Myovant Sciences was acquired by Sumitovant of Sumitomo Pharma for $27.00 per share in cash via a merger transaction. Based on J.P. Morgan's valuations for $MYOV, Sumitovant was willing to pay $29.50 per share in a competitive bidding scenario. Investors suspect that they were misled in voting for a merger at a price that was less than Myovant’s full and fair value. To claim compensation: https://11thestate.com/cases/myovant-mna-lawsuit
Quad_
Posted - 1 year ago
$AUPH It’s always important to remember there will be wolves in sheep’s clothing on StockTwits. Happened in $MYOV with my beloved friend Fade. To this day, I’m pretty sure Fade was Myrtle’s bitch. Some knowledge, fancy charts, and then some FUD. Some of that is happening here, too. This will get bought. Just be careful who you listen to here. Chances are you’re talking to some mid level hedge fund guy that just got over a bender and has to protect his firms short position… or accumulate.
mrmark47299
Posted - 10/31/23
$TTOO I did this for 2 year's with $MYOV
GOT BOUGHT OUT, AND THEN I THREW IT ALL AWAY WITH $TTOO. (BUT I AINT SELLING)!
mrmark47299
Posted - 10/31/23
@momneedsnewshoes I did this for 2 year's with $MYOV
GOT BOUGHT OUT, AND THEN I THREW IT ALL AWAY WITH $TTOO. (BUT I AINT SELLING)!
Auphiliate
Posted - 10/26/23
@Goodfriend98 @Valleycapital @TonyK666 Learned my lesson here. Best to go with biotechs with better sales potential. $TGTX and most recently $MYOV for me! Lupkynis is a good product but smaller patient population and too easy for greedy management to stuff their pockets then hide behind a million excuses. Yes, there are many other similar biotechs. I will avoid them as well. 🧐
fin_researcher
Posted - 10/24/23
Investors who faced losses from the $MYOV stock dip may have a chance for recovery. https://11thestate.com/cases/myovant-mna-lawsuit